Insider Trends: Insider at USANA Health Sciences Acquires Stock Via Conversion of Option/Derivative Security Sells Portion to Pay Tax, Buy Trend Intact
06:53 PM EST, 02/05/2021 (MT Newswires) -- Joshua Foukas, Chief Legal Officer, exercised options/derivative securities for 4,614 shares of USANA Health Sciences (USNA) and sold 1,956 shares in the company for $164,068 to meet tax obligations on Feb 03, 2021. After accounting for tax obligations this transaction resulted in a net acquisition of 2,658 company shares. Following the Form 4 filing with the SEC, Foukas owns 2,658 shares of company stock, with a market value, based on the prior-day closing price, of $226,408.
In the 90 days previous to the date of this filing, there have been 2 insider transactions reported to the SEC for USANA Health Sciences. These transactions came from the activity of one insider that resulted in a net acquisition of 4,916 company shares. Relative to the preceding 90-day window of time, there were 35 transactions from 16 insiders and resulted in the net disposition of 597,077 shares.
This is less than the average level of insider transactions in the 19-company Personal Products peer group over the last 90-day period. Activity in the peer group averaged 158.5 transactions per company, and disposition of 89,952 shares on average.
SEC Story Link http://www.sec.gov/Archives/edgar/data/896264/000117911021001360/xslF345X03/edgar.xml
This report does not constitute a recommendation to purchase or sell any security and the analysts are not registered investment advisors. Further analysis is recommended before undertaking any position in any security. Any risks are solely the responsibility of the buyer/seller. The authors, publishers and distributors of the MT Newswires Live Briefs service and any associates thereof accept no liability for the content or actions taken by anyone or institution utilizing this report.